Preclinical and animal studies with limited human data
Peptides with preclinical evidence and limited human data
Strong animal study evidence with promising early human data. Clinical trials are ongoing or needed.
These peptides show promise but need more human research. Use should be carefully monitored by your healthcare provider.
All peptides on Peptide Ledger, regardless of evidence level, require a prescription and should only be used under the guidance of a licensed healthcare provider.
BPC-157
Recovery Stack
Modified Growth Hormone Releasing Hormone
GHK-Cu
Triple Recovery Stack
Master Antioxidant
Glutathione Rectal
GnRH RDT
Growth Hormone Secretagogue
Selank
Selank/Semax
Thymosin Beta-4